Research/Areas of Interest
Reproductive Policy, Health System Performance, Health Economics, Healthcare Quality
Education
- PhD, London School of Economics and Political Science, London, United Kingdom, 2023
- MSc, London School of Economics (LSE) & London School of Hygiene and Tropical Medicine (LSHTM), London, United Kingdom
- BA, Wesleyan University, Middletown, United States
Biography
Liana Woskie is an Assistant Professor in Tufts' Department of Community Health and joined the university after completing her PhD at the London School of Economics in 2023. She also holds an adjunct faculty appointment at Brown University and a visiting scientist role within Harvard University's Department of Global Health and Population.
Dr. Woskie evaluates health system performance and the degree to which systems are held accountable to patients. She was named an H. F. Guggenheim Emerging Scholar for her dissertation project: "Quantifying Structural Violence: Female Sterilization and Normalized State Repression in Healthcare," for research on causes and manifestations of violence against women. Over the past 12 years she has also managed large-scale academic projects on issues related to health financing, iatrogenic harm, pandemic response and aid accountability. In 2015-16 she served as Coordinator for the Lancet Independent Panel on the Global Governance Response to Ebola. She built on this experience during COVID-19 by examining differentially curtailed population mobility and human rights during national lockdowns in India, Panama and across the European Union. Additional work on comparative health financing (with Papanicolas and Jha) was named Top Article of the Decade by the Journal of the American Medical Association (JAMA), informing both congressional and senate hearings on the US' disproportionate health spending.
She is currently launching a portfolio of research on pharmaceutical abortion with a focus on the differential regulation of mifepristone across countries. This project is supported by an NIH Building Interdisciplinary Research Careers in Women's Health (BIRCWH) career development award, which will begin May 2024.
Dr. Woskie evaluates health system performance and the degree to which systems are held accountable to patients. She was named an H. F. Guggenheim Emerging Scholar for her dissertation project: "Quantifying Structural Violence: Female Sterilization and Normalized State Repression in Healthcare," for research on causes and manifestations of violence against women. Over the past 12 years she has also managed large-scale academic projects on issues related to health financing, iatrogenic harm, pandemic response and aid accountability. In 2015-16 she served as Coordinator for the Lancet Independent Panel on the Global Governance Response to Ebola. She built on this experience during COVID-19 by examining differentially curtailed population mobility and human rights during national lockdowns in India, Panama and across the European Union. Additional work on comparative health financing (with Papanicolas and Jha) was named Top Article of the Decade by the Journal of the American Medical Association (JAMA), informing both congressional and senate hearings on the US' disproportionate health spending.
She is currently launching a portfolio of research on pharmaceutical abortion with a focus on the differential regulation of mifepristone across countries. This project is supported by an NIH Building Interdisciplinary Research Careers in Women's Health (BIRCWH) career development award, which will begin May 2024.